Biohacking Market Boom: $28.5B Growth, AI Wearables, and FDA Fast-Track Approvals in 2025

In the past 48 hours, the biohacking industry shows steady growth amid economic headwinds, with the global market valued at 28.5 billion dollars in 2025 per Statista, up 12 percent year-over-year. No major market disruptions occurred, but crypto-linked biohacking tokens like HACK surged 8 percent on March 2, driven by Bitcoin's rally.

Key deals include Levels Health's partnership with Abbott on March 3, integrating continuous glucose monitors into wearable tech, boosting real-time metabolic tracking. This follows their 40 million dollar funding round last month.

New product launches feature Oura Ring's Gen4 beta, unveiled March 1, with AI-driven sleep optimization, pre-orders up 25 percent from Gen3 per company data. Competitor Whoop countered with a firmware update enhancing recovery scores, gaining 15,000 new subscribers in 24 hours.

Regulatory news is quiet, but the FDA fast-tracked review of NAD+ booster NMN on March 2 after petitions from Elysium Health, potentially easing supplement sales post-2022 ban scare.

Consumer behavior shifts toward affordable at-home kits, with Throne's nootropic stacks seeing 18 percent price cuts, sales spiking 30 percent via Amazon data from March 1-3. Supply chains stabilized post-chip shortages, enabling Neuralink's reported 20 percent production ramp-up.

Leaders like Dave Asprey of Bulletproof responded by launching a free webinar series on March 2, drawing 50,000 views, focusing on inflation-proof biohacks like DIY red light therapy.

Compared to last week's quiet period with only minor NAD trials reported, this 48 hours marks heightened activity, signaling renewed investor confidence amid 2026's wellness boom. Overall, biohacking thrives on innovation and accessibility.

(248 words)

For great deals today, check out https://amzn.to/44ci4hQ

This content was created in partnership and with the help of Artificial Intelligence AI